Colonial Trust Advisors Catalent, Inc. Transaction History

Colonial Trust Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$32.18 - $46.57 $514 - $745	-16 Reduced 80.0%	4 $0
Q3 2023 Nov 13, 2023	BUY	$44.2 - $50.2 $88 - $100	2 Added 11.11%	20 $0
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $254 - $538	8 Added 80.0%	18 $0
Q1 2023 May 11, 2023	BUY	$45.44 - $74.26 $136 - $222	3 Added 42.86%	10 $0
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $289 - $567	7 New	7 $0

511

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Colonial Trust Advisors, based on Form 13F filings with the SEC.

Stay updated on Colonial Trust Advisors with notifications on news.